Approval is sought for phase 2 of the LCR Ventures project (now rebranded “LYVA Labs”) which received indicative approval from the Combined Authority on 23 July 2021 subject to passing through the Strategic Investment Fund assurance process. The project is a key delivery aspect of the recently launched LCR Innovation Prospectus and will help address the City Region’s target of investing 5% of GVA in R&D by 2030.
Phase 2 will (i) extend the focus of phase 1 beyond Health & Life Sciences to support the commercialising the City Region’s knowledge base, (ii) help larger City Region businesses to identify new R&D investment opportunities and (iii) develop new large-scale research consortia to leverage public and private sector funding opportunities.
Decision type: Key
Reason Key: Financial and Community Impact;
Decision status: For Determination
Local Authorities affected: (All Local Authorities);
Notice of proposed decision first published: 10/05/2022
Anticipated restriction: Part exempt - View reasons
Decision due: 10 Jun 2022 by Liverpool City Region Combined Authority
Lead director: Dr Aileen Jones
Contact: Raphael Miller Email: email@example.com.
Liverpool City Region External Investment Panel
Making Representations: Dr Aileen Jones, Executive Director Investment and Delivery Email: firstname.lastname@example.org